Latest Insider Transactions at Nrx Pharmaceuticals, Inc. (NRXP)
This section provides a real-time view of insider transactions for Nrx Pharmaceuticals, Inc. (NRXP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of NRX Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of NRX Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 17
2024
|
Jonathan C Javitt Chairman and Chief Scientist |
BUY
Open market or private purchase
|
Direct |
40,000
+32.09%
|
$40,000
$1.17 P/Share
|
|
Aug 30
2023
|
Aaron Gorovitz |
BUY
Open market or private purchase
|
Indirect |
35,000
+25.0%
|
$0
$0.32 P/Share
|
|
Aug 30
2023
|
Chaim Hurvitz |
BUY
Open market or private purchase
|
Direct |
70,000
+10.94%
|
$0
$0.29 P/Share
|
|
Aug 23
2023
|
Jonathan C Javitt Chairman and Chief Scientist |
BUY
Open market or private purchase
|
Direct |
100,000
+18.3%
|
$0
$0.33 P/Share
|
|
Aug 22
2023
|
Jonathan C Javitt Chairman and Chief Scientist |
BUY
Open market or private purchase
|
Direct |
200,000
+36.61%
|
$0
$0.32 P/Share
|
|
Dec 16
2022
|
Seth Van Voorhees CHIEF FINANCIAL OFFICER |
BUY
Open market or private purchase
|
Direct |
30,000
+39.3%
|
$30,000
$1.1 P/Share
|
|
Dec 16
2022
|
Stephen H Willard CHIEF EXECUTIVE OFFICER |
BUY
Open market or private purchase
|
Direct |
50,000
+50.0%
|
$50,000
$1.17 P/Share
|
|
Dec 07
2022
|
Jonathan C Javitt Chairman and Chief Scientist |
SELL
Open market or private sale
|
Indirect |
400,000
-3.01%
|
$400,000
$1.0 P/Share
|
|
Nov 30
2022
|
Daniel C. Javitt > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
8,441
-0.09%
|
$8,441
$1.5 P/Share
|
|
Nov 29
2022
|
Daniel C. Javitt > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
13,730
-0.14%
|
$13,730
$1.5 P/Share
|
|
Nov 28
2022
|
Patrick John Flynn |
BUY
Open market or private purchase
|
Direct |
1,750
+50.0%
|
$1,750
$1.25 P/Share
|
|
Nov 28
2022
|
Patrick John Flynn |
BUY
Open market or private purchase
|
Indirect |
10,000
+6.04%
|
$10,000
$1.25 P/Share
|
|
Nov 25
2022
|
Seth Van Voorhees CHIEF FINANCIAL OFFICER |
BUY
Open market or private purchase
|
Indirect |
16,337
+28.69%
|
$16,337
$1.11 P/Share
|
|
Nov 18
2022
|
Chaim Hurvitz |
BUY
Open market or private purchase
|
Direct |
40,408
+7.48%
|
$40,408
$1.1 P/Share
|
|
Nov 17
2022
|
Chaim Hurvitz |
BUY
Open market or private purchase
|
Direct |
171,780
+27.21%
|
$171,780
$1.08 P/Share
|
|
Nov 17
2022
|
Daniel C. Javitt > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
33,018
-0.34%
|
$33,018
$1.05 P/Share
|
|
Nov 16
2022
|
Chaim Hurvitz |
BUY
Open market or private purchase
|
Direct |
287,812
+50.0%
|
$0
$0.99 P/Share
|
|
Nov 16
2022
|
Daniel C. Javitt > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
133,719
-1.36%
|
$133,719
$1.02 P/Share
|
|
Nov 11
2022
|
Daniel C. Javitt > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
49,200
-0.5%
|
$49,200
$1.01 P/Share
|
|
Jul 29
2022
|
Daniel C. Javitt > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
784,063
-7.36%
|
$784,063
$1.01 P/Share
|
|
Jul 01
2022
|
Daniel C. Javitt > 10% Shareholder |
SELL
Bona fide gift
|
Indirect |
2,000,000
-15.8%
|
-
|
|
Jun 07
2022
|
Daniel C. Javitt > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
86,459
-0.68%
|
$0
$0.65 P/Share
|
|
Jun 06
2022
|
Daniel C. Javitt > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
115,657
-0.9%
|
$0
$0.67 P/Share
|
|
Jun 03
2022
|
Daniel C. Javitt > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
243,596
-1.86%
|
$0
$0.7 P/Share
|
|
Jun 01
2022
|
Jonathan C Javitt Chairman and Chief Scientist |
BUY
Open market or private purchase
|
Direct |
100,000
+40.6%
|
$5,800,000
$58.0 P/Share
|
|
Sep 15
2021
|
Robert Besthof Interim CEO |
SELL
Open market or private sale
|
Direct |
40,000
-62.78%
|
$440,000
$11.76 P/Share
|
|
Sep 02
2021
|
Alessandra Daigneault General Counsel & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
31,584
+39.71%
|
$94,752
$3.07 P/Share
|
|
Aug 26
2021
|
Herbert Raymond Mc Master Director |
BUY
Exercise of conversion of derivative security
|
Direct |
18,300
+50.0%
|
$36,600
$2.22 P/Share
|
|
Aug 23
2021
|
Alessandra Daigneault General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
33,715
-100.0%
|
$438,295
$13.11 P/Share
|
|
Aug 19
2021
|
Alessandra Daigneault General Counsel & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
27,395
+44.83%
|
$82,185
$3.07 P/Share
|
|
Aug 16
2021
|
Robert Besthof Interim CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
63,710
+50.0%
|
$0
$0.2 P/Share
|
|
Jul 16
2021
|
Daniel C. Javitt > 10% Shareholder |
SELL
Bona fide gift
|
Indirect |
869,188
-3.16%
|
-
|
|
May 24
2021
|
Alessandra Daigneault General Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
6,320
+50.0%
|
-
|
|
May 24
2021
|
Patrick John Flynn |
BUY
Grant, award, or other acquisition
|
Indirect |
432,750
+50.0%
|
-
|
|
May 24
2021
|
Sharon Glied Director |
BUY
Grant, award, or other acquisition
|
Indirect |
13,168
+50.0%
|
-
|
|
May 24
2021
|
Aaron Gorovitz |
BUY
Grant, award, or other acquisition
|
Indirect |
41,686
+50.0%
|
-
|
|
May 24
2021
|
Chaim Hurvitz |
BUY
Grant, award, or other acquisition
|
Indirect |
1,644,793
+50.0%
|
-
|
|
May 24
2021
|
Daniel C. Javitt > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Indirect |
13,971,864
+50.0%
|
-
|
|
May 24
2021
|
Jonathan C Javitt Chairman and Chief Scientist |
BUY
Grant, award, or other acquisition
|
Indirect |
14,770,997
+50.0%
|
-
|
|
May 24
2021
|
Jonathan C Javitt Chairman and Chief Scientist |
BUY
Grant, award, or other acquisition
|
Direct |
46,332
+50.0%
|
-
|
|
May 24
2021
|
Daniel Troy Director |
BUY
Grant, award, or other acquisition
|
Direct |
43,093
+50.0%
|
-
|
|
May 24
2021
|
Brac Lending Group LLC > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Direct |
869,565
-60.72%
|
-
|
|
May 24
2021
|
Big Rock Partners Sponsor, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
27,250
+4.99%
|
-
|
|
May 24
2021
|
Big Rock Partners Sponsor, LLC > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
5,435
-1.09%
|
-
|
|
Mar 13
2020
|
Polar Asset Management Partners Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
29,464
-5.69%
|
$294,640
$10.6 P/Share
|